PALAZZO, LUCA
 Distribuzione geografica
Continente #
AS - Asia 50
NA - Nord America 15
EU - Europa 1
Totale 66
Nazione #
SG - Singapore 42
US - Stati Uniti d'America 15
KR - Corea 5
CN - Cina 3
GB - Regno Unito 1
Totale 66
Città #
Singapore 38
Santa Clara 5
Seoul 5
Guangzhou 3
Ashburn 1
Fort Worth 1
Oxford 1
Totale 54
Nome #
The DarT/DarG Toxin-Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies 5
ENPP1 processes protein ADP-ribosylation in vitro 4
Targeting ADP-ribosylation as an antimicrobial strategy 4
CAF-1 subunits levels suggest combined treatments with PARP-inhibitors and ionizing radiation in advanced HNSCC 4
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders 4
Exploitation of DarT/DarG biology for a rational design of antimicrobial agents 4
Serine ADP-ribosylation reversal by the hydrolase ARH3 3
(ADP-ribosyl)hydrolases: structure, function, and biology 3
Serine is a new target residue for endogenous ADP-ribosylation on histones 3
Requirement for proteolysis in spindle assembly checkpoint silencing 3
null 3
ADP-ribosylation: new facets of an ancient modification 3
Progress and outlook in studying the substrate specificities of PARPs and related enzymes 3
ADP-ribosylation signalling and human disease 2
ATM controls proper mitotic spindle structure 2
MacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria 2
Studying Catabolism of Protein ADP-Ribosylation 2
Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor 2
Serine is the major residue for ADP-ribosylation upon DNA damage 2
PARPs in genome stability and signal transduction: implications for cancer therapy 2
Processing of protein ADP-ribosylation by Nudix hydrolases 2
Mono(ADP-ribosyl)ation enzymes and NAD+ metabolism. A Focus on Diseases and Therapeutic Perspectives 2
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs 2
Requirement for proteolysis in spindle assembly checkpoint silencing 1
PARPs and PAR as novel pharmacological targets for the treatment of stress granule-associated disorders 1
Role for Non-Proteolytic Control of M-phase Promoting Factor Activity at M-phase Exit 1
Totale 69
Categoria #
all - tutte 487
article - articoli 443
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 20
Totale 950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202411 0 0 0 0 0 0 0 0 0 0 8 3
2024/202558 1 3 52 2 0 0 0 0 0 0 0 0
Totale 69